ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 192 out of 2094

$555K Total Retail Price of All Prescriptions

Rank: 405 out of 2094

421 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,981 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 365 318 1 1
OMEPRAZOLE 355 318 2 4
FUROSEMIDE 353 318 3 6
LEVOTHYROXINE SODIUM 344 329 4 3
LISINOPRIL 314 284 5 7
AMLODIPINE BESYLATE 287 265 6 2
WARFARIN SODIUM 259 250 7 11
FAMOTIDINE 231 224 8 34
METOPROLOL TARTRATE 208 181 9 10
DONEPEZIL HCL 196 196 10 20
METOPROLOL SUCCINATE 175 163 11 9
CARVEDILOL 163 161 12 19
POTASSIUM CHLORIDE 154 132 13 24
METFORMIN HCL 142 130 14 8
LIDOCAINE 140 133 15 217
ATORVASTATIN CALCIUM 129 119 16 5
MELOXICAM 127 118 17 49
LANTUS 111 111 18 66
HYDROCHLOROTHIAZIDE 111 98 18 12
MUPIROCIN 109 109 20 117
OXYCODONE-ACETAMINOPHEN 109 93 S2 20 40
DIVALPROEX SODIUM 103 68 22 69
CLOPIDOGREL 103 97 22 22
SANTYL 96 92 24 114
LOSARTAN POTASSIUM 90 82 25 17
FLUTICASONE PROPIONATE 90 78 25 41
SERTRALINE HCL 88 87 27 26
PREDNISONE 87 65 28 54
CYMBALTA 86 67 29 61
TRAZODONE HCL 81 81 30 72
PANTOPRAZOLE SODIUM 81 78 30 37
GABAPENTIN 79 68 32 23
GLIMEPIRIDE 78 70 33 31
LYRICA 78 50 33 85
JANUVIA 74 74 35 35
METOLAZONE 70 69 36 216
ESCITALOPRAM OXALATE 70 67 36 46
NOVOLOG 69 67 38 116
PRAVASTATIN SODIUM 69 54 38 18
LANTUS SOLOSTAR 68 65 40 76
ZOLPIDEM TARTRATE 67 47 41 14
LEVOFLOXACIN 67 58 41 70
LIDODERM 67 67 41 59
DIOVAN 66 54 44 13
TAMSULOSIN HCL 65 65 45 29
NOVOLOG FLEXPEN 64 60 46 142
XIFAXAN 61 61 47 354
AZITHROMYCIN 61 51 47 27
ENALAPRIL MALEATE 59 44 49 25
MIRTAZAPINE 59 59 49 43
NEXIUM 57 57 51 16
TRIAMTERENE-HCTZ 57 44 51 87
NAMENDA 55 46 53 32
CITALOPRAM HBR 54 54 54 47
ALLOPURINOL 53 50 55 50
DIGOXIN 52 39 56 51
SPIRIVA 52 44 56 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.